Cite

HARVARD Citation

    Papageorgiou, S. et al. (2016). Treatment with 5-Azacytidine improves clinical outcome in high-risk MDS patients in the 'real life' setting: A single center observational study. Hematology. 21 (1), pp. 34-41. [Online]. 
  
Back to record